Study of AK112 in the Treatment of Advanced Gynecological Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Cancer Metastatic
- Cervical Neoplasm
- Endometrial Neoplasms
- Gynecologic Cancer
- Ovarian Neoplasms
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 75 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04870177
- Collaborators
- Not Provided
- Investigators
- Study Chair: Beihua Kong, MD Qilu Hospital of Shandong University Study Chair: Qi Zhou, MD Chongqing University Cancer Hospital
Get Well Soon